NASDAQ:DRIO DarioHealth (DRIO) Stock Price, News & Analysis $0.52 -0.03 (-5.09%) As of 03:18 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About DarioHealth Stock (NASDAQ:DRIO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get DarioHealth alerts:Sign Up Key Stats Today's Range$0.52▼$0.5750-Day Range$0.43▼$0.7252-Week Range$0.38▼$1.55Volume355,326 shsAverage Volume405,671 shsMarket Capitalization$23.75 millionP/E RatioN/ADividend YieldN/APrice Target$2.00Consensus RatingModerate Buy Company Overview DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York. Read More DarioHealth Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks27th Percentile Overall ScoreDRIO MarketRank™: DarioHealth scored higher than 27% of companies evaluated by MarketBeat, and ranked 830th out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingDarioHealth has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageDarioHealth has received no research coverage in the past 90 days.Read more about DarioHealth's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for DarioHealth are expected to grow in the coming year, from ($1.18) to ($1.06) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of DarioHealth is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of DarioHealth is -0.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDarioHealth has a P/B Ratio of 0.27. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about DarioHealth's valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.52% of the float of DarioHealth has been sold short.Short Interest Ratio / Days to CoverDarioHealth has a short interest ratio ("days to cover") of 19.2, which indicates bearish sentiment.Change versus previous monthShort interest in DarioHealth has recently increased by 2.70%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDarioHealth does not currently pay a dividend.Dividend GrowthDarioHealth does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted7.52% of the float of DarioHealth has been sold short.Short Interest Ratio / Days to CoverDarioHealth has a short interest ratio ("days to cover") of 19.2, which indicates bearish sentiment.Change versus previous monthShort interest in DarioHealth has recently increased by 2.70%, indicating that investor sentiment is decreasing. News and Social Media0.6 / 5News Sentiment-1.00 News SentimentDarioHealth has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.70 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for DarioHealth this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for DRIO on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, DarioHealth insiders have not sold or bought any company stock.Percentage Held by Insiders11.20% of the stock of DarioHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 33.39% of the stock of DarioHealth is held by institutions.Read more about DarioHealth's insider trading history. Receive DRIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DarioHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address DRIO Stock News HeadlinesDarioHealth Announces 20-to-1 Reverse Stock SplitAugust 25 at 8:00 AM | prnewswire.comSome Analysts Just Cut Their DarioHealth Corp. (NASDAQ:DRIO) EstimatesAugust 14, 2025 | finance.yahoo.comMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.August 26 at 2:00 AM | Brownstone Research (Ad)DarioHealth Corp. (DRIO) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | seekingalpha.comDarioHealth price target lowered to $1.25 from $1.50 at StifelAugust 14, 2025 | msn.comDarioHealth Corp.: DarioHealth Reports Second Quarter 2025 Financial and Operating ResultsAugust 13, 2025 | finanznachrichten.deDarioHealth reports Q2 EPS 18c, consensus (10c)August 13, 2025 | msn.comDarioHealth Reports Second Quarter 2025 Financial and Operating ResultsAugust 12, 2025 | prnewswire.comSee More Headlines DRIO Stock Analysis - Frequently Asked Questions How have DRIO shares performed this year? DarioHealth's stock was trading at $0.7861 at the start of the year. Since then, DRIO shares have decreased by 28.4% and is now trading at $0.5630. How were DarioHealth's earnings last quarter? DarioHealth Corp. (NASDAQ:DRIO) issued its quarterly earnings results on Wednesday, May, 14th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by $0.07. The firm earned $6.75 million during the quarter, compared to the consensus estimate of $7.48 million. DarioHealth had a negative net margin of 162.73% and a negative trailing twelve-month return on equity of 65.89%. Read the conference call transcript. When did DarioHealth's stock split? Shares of DarioHealth reverse split on the morning of Thursday, August 28th 2025.The 1-20 reverse split was announced on Monday, August 25th 2025. The number of shares owned by shareholders will be adjusted after the closing bell on Wednesday, August 27th 2025. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. Does DarioHealth have any subsidiaries? DarioHealth subsidiaries include these companies: PsyInnovations Inc., Upright Technologies Ltd., Labstyle Innovation Ltd., PsyInnovations India Private Limited., and Upright Technologies Inc.. Who are DarioHealth's major shareholders? DarioHealth's top institutional investors include AMH Equity Ltd (0.47%) and XTX Topco Ltd (0.14%). Insiders that own company stock include Erez Raphael and Steven Charles Nelson. View institutional ownership trends. How do I buy shares of DarioHealth? Shares of DRIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of DarioHealth own? Based on aggregate information from My MarketBeat watchlists, some other companies that DarioHealth investors own include NVIDIA (NVDA), Meta Platforms (META), Pfizer (PFE), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM) and Tesla (TSLA). Company Calendar Last Earnings5/14/2025Today8/26/2025Next Earnings (Estimated)11/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:DRIO CIK1533998 Webwww.mydario.com Phone(833) 914-3796Fax972-4770-4059Employees200Year Founded2011Price Target and Rating Average Price Target for DarioHealth$2.00 High Price Target$3.00 Low Price Target$1.00 Potential Upside/Downside+263.6%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($0.66) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$42.75 million Net Margins-162.73% Pretax Margin-162.13% Return on Equity-65.89% Return on Assets-39.03% Debt Debt-to-Equity Ratio0.48 Current Ratio3.30 Quick Ratio2.83 Sales & Book Value Annual Sales$27.04 million Price / Sales0.93 Cash FlowN/A Price / Cash FlowN/A Book Value$2.11 per share Price / Book0.26Miscellaneous Outstanding Shares45,500,000Free Float40,401,000Market Cap$25.03 million OptionableOptionable Beta1.24 Social Links Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (NASDAQ:DRIO) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DarioHealth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share DarioHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.